En Es
Categorías

QIAGEN

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initia ...
Productos Covid-19NoticiasResumen
Close

Covid-19 QIAGEN

Laboratorio clínico

Viral RNA UM Kit
QIAprep& Viral RNA UM Kit

The QIAprep& Viral RNA UM Kit combines a liquid-based sample preparation step completed in only two minutes with real-time RT-PCR detection in a streamlined workflow. Users can automate this method with standard lab equipment for any throughput, assay and reaction need from single to multiplex testing. The kit is compatible with dual-labeled probes, e.g., TaqMan probes in multiplex one-step RT-PCR detection of one or more targets (altogether, up to 4 assays including the internal controls).
Mas detalles

SARS-CoV-2 Primer Panel
QIAseq SARS-CoV-2 Primer Panel

The QIAseq SARS-CoV-2 Primer Panel combines both reverse transcription and whole genome enrichment of the viral RNA for targeting SARS-CoV-2 to generate amplicons for downstream library creation. When paired with a QIAseq FX DNA Library UDI Kit, sequencing-ready libraries compatible with Illumina platforms can be constructed. QIAseq SARS-CoV-2 primer pools utilize designs from the ARTIC V3 primers which have also gone through an in silico check to reduce chances for dimerization during sample enrichment.
Mas detalles

SARS-CoV-2 Antigen Testing Device
QIAreach eHub

The QIAreach eHub portable SARS-CoV-2 antigen testing device, in combination with QIAreach assay eSticks, provides a simplified workflow for multiple in vitro diagnostic tests, using state-of-the-art nanoparticle fluorescence detection technology. QIAreach assay eSticks are single-use tests that include a lateral flow strip and optoelectronics that perform test measurements and interpret results. The QIAreach eHub provides power to the QIAreach test eStick to run the test when the test eStick is connected to any one of the eHub eStick ports. The QIAreach eHub visually communicates test progress and results to the user via a display screen specific to each eHub port.
Mas detalles

SARS-CoV-2 RUO Solution
QuantiFERON SARS-CoV-2 RUO

The QuantiFERON SARS-CoV-2 RUO solution is an original combination of blood collection tubes containing innovative specific peptides formulated to stimulate lymphocytes in heparinized whole blood involved in cell-mediated immunity. Plasma from the stimulated samples can then be used for detection of IFN-γ using a simple ELISA. The QuantiFERON SARS-CoV-2 RUO solution is composed of several components that can be ordered separately or combined to provide better research insights on patients’ immune status.
Mas detalles

Flu A/SARS-CoV-2 Test
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test

The NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test is a multiplex polymerase chain reaction (PCR) test that detects and differentiates influenzas A and B, respiratory syncytial virus (RSV) and SARS-CoV-2 infections within 80 minutes. The respiratory test takes advantage of the NeuMoDx 96 and NeuMoDx 288 molecular systems’ automated three-step workflow and has obtained CE-IVD approval for the use of saliva samples collected with the NeuMoDx Saliva Collection Kit, which includes a collection vial, stabilization tube and pipette.
Mas detalles

SARS-CoV-2 Assay
NeuMoDx SARS-CoV-2 Assay

The NeuMoDx SARS-CoV-2 Assay is a real-time RT-PCR diagnostic test intended for the qualitative detection of SARS-CoV-2 coronavirus RNA in nasal, nasopharyngeal and oropharyngeal swabs in transport medium, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. This test is performed on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems and is also for use with saliva specimens that are collected within a healthcare setting by individuals using the NeuMoDx Saliva Collection Kit when determined to be appropriate by a healthcare provider.
Mas detalles

Molecular System
NeuMoDx 96

The NeuMoDx 96 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the system is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
Mas detalles

Molecular System
NeuMoDx 288

The NeuMoDx 288 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the instrument is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
Mas detalles

SARS-CoV-2 Antigen Test
QIAreach SARS-CoV-2 Antigen Test

The QIAreach SARS-CoV-2 Antigen Test is a scalable, digital assay for the in vitro detection of the SARS-CoV-2 nucleocapsid protein antigen that allows testing up to eight patients simultaneously for SARS-CoV-2 infection with the first positive results in just two minutes. As part of the complete QIAreach solution for SARS-CoV-2 testing, the test will run simultaneously with the QIAreach Anti-SARS-CoV-2 Total Test on a single QIAreach eHub.
Mas detalles

SARS-CoV-2 Antibody Test
QIAreach Anti-SARS-CoV-2 Total Test

The QIAreach Anti-SARS-CoV-2 Total Test is a rapid, digital lateral flow serological test, using nanoparticle fluorescence, intended for qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma (heparin, EDTA). It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Mas detalles

PANEL RESPIRATORIO SARS-COV-2
QIAstat-Dx Respiratory SARS-CoV-2 Panel

El panel QIAstat-Dx Respiratory SARS-CoV-2 es un cartucho sindrómico multiplex que detecta y diferencia 21 objetivos respiratorios, incluido el SARS-CoV-2 de hisopos nasofaríngeos (NPS) eluídos en medios de transporte universal (MTU).
Mas detalles
Close

Noticias of QIAGEN

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

20 May 2022
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.
Más info

Qiagen hace una sociedad con Sysmex para el desarrollo y la comercialización de diagnósticos acompañantes para el cáncer

24 Aug 2021
Qiagen hace una sociedad con Sysmex para el desarrollo y la comercialización de diagnósticos acompañantes para el cáncer
QIAGEN NV (Venlo, Países Bajos) y Sysmex Corporation (Kobe, Japón) firmaron una alianza estratégica global para el desarrollo y comercialización de diagnósticos complementarios del cáncer, que aprovechará tanto el liderazgo de QIAGEN en este campo como la tecnología Plasma-Safe-SeqS de Sysmex para secuenciación de próxima generación (NGS).
Más info

Qiagen Partners with Sysmex for Development and Commercialization of Cancer Companion Diagnostics

02 Jul 2021
Qiagen Partners with Sysmex for Development and Commercialization of Cancer Companion Diagnostics
QIAGEN N.V. (Venlo, Netherlands) and Sysmex Corporation (Kobe, Japan) have entered into a global strategic alliance for the development and commercialization of cancer companion diagnostics, which will leverage both QIAGEN’s leadership in this field and Sysmex’s Plasma-Safe-SeqS technology for next generation sequencing (NGS).
Más info

QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short

14 Aug 2020
QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short
QIAGEN N.V. (Venlo, Netherlands) plans to continue executing its growth strategy aimed at creating significant value for shareholders and other stakeholders after the voluntary public takeover offer by Thermo Fisher Scientific Inc. (Waltham, MA, USA) failed to achieve the minimum 66.67% acceptance threshold from QIAGEN shareholders.
Más info

QIAGEN Enters into Agreement to Acquire STAT-Dx

13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Más info

Qiagen Acquires Bioinformatics Firm OmicSoft

12 Jan 2017
Qiagen Acquires Bioinformatics Firm OmicSoft
QIAGEN N.V., a provider of sample and assay technologies, has acquired OmicSoft Corporation, which focuses on biomarker data management, visualization, and analysis.
Más info
Close

Sobre QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including complete kits for pre-defined applications in sample preparation and analysis, and individual enzymes and reagents. It also offers instruments for automating the full range of laboratory procedures, from the initial sample preparation to the final test result.

Actualizado

DNA Blood Kits
EZ1&2 DNA Blood Kits

EZ1&2 DNA Blood Kits contain all required reagents and labware for rapid, automated purification of DNA from 200-350 μl whole blood samples or buffy coat samples using magnetic-particle technology. The reagents are supplied in prefilled and sealed reagent cartridges, ensuring speed and convenience in loading the instrument.
Mas detalles

HPV Test
careHPV Test

QIAGEN’s careHPV Test allows testing for high-risk HPV in limited resource settings and can be used for primary, stand-alone screening in women 30 years and older to determine high-risk HPV infection, which is a risk factor for developing cervical cancer. It can be run by a healthcare worker with proper training and without formal laboratory skills and may be run on electricity or a battery with an inverter, making it portable and adaptable.
Mas detalles

HPV PCR Test
QIAscreen HPV PCR Test

The QIAscreen HPV PCR Test is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (HPV) DNA of 15 (likely) (1) high-risk HPV genotypes. The test is part of QIAGEN’s family of PCR-based women’s health tests on the Rotor-Gene Q instrument, which includes tests for C. trachomatis, N. gonorrhoeae, and T. vaginalis.
Mas detalles

Laboratorio clínico

DNA Blood Kits
EZ1&2 DNA Blood Kits

EZ1&2 DNA Blood Kits contain all required reagents and labware for rapid, automated purification of DNA from 200-350 μl whole blood samples or buffy coat samples using magnetic-particle technology. The reagents are supplied in prefilled and sealed reagent cartridges, ensuring speed and convenience in loading the instrument.
Mas detalles

HPV Test
careHPV Test

QIAGEN’s careHPV Test allows testing for high-risk HPV in limited resource settings and can be used for primary, stand-alone screening in women 30 years and older to determine high-risk HPV infection, which is a risk factor for developing cervical cancer. It can be run by a healthcare worker with proper training and without formal laboratory skills and may be run on electricity or a battery with an inverter, making it portable and adaptable.
Mas detalles

HPV PCR Test
QIAscreen HPV PCR Test

The QIAscreen HPV PCR Test is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (HPV) DNA of 15 (likely) (1) high-risk HPV genotypes. The test is part of QIAGEN’s family of PCR-based women’s health tests on the Rotor-Gene Q instrument, which includes tests for C. trachomatis, N. gonorrhoeae, and T. vaginalis.
Mas detalles

Virus/Pathogen Kits
QIAsymphony DSP

QIAsymphony DSP virus/pathogen kits, in combination with the QIAsymphony SP, enable automated purification of viral nucleic acids and bacterial DNA from a broad range of sample materials for in vitro diagnostic use. Optimized protocols provide high yields of pure nucleic acids, and flexible elution volumes allow nucleic acid concentration to be easily optimized for each downstream application. Novel, prefilled reagent cartridges reduce setup time and minimize manual handling while bar code reading enables full tracking of reagents.
Mas detalles

Nucleic Acid Purification Instrument
EZ1 Advanced XL

The EZ1 Advanced XL performs automated nucleic acid purification for a wide range of sample types relevant to molecular diagnostics, human identity testing, forensics, biomedical research, and gene expression analysis. Its ease of use enables fast and reproducible purification, without the need for specialized training or previous experience with laboratory automation.
Mas detalles

Automated Nucleic Acid Extractor
QIAcube Connect MDx

The QIAcube Connect MDx nucleic acid extractor is designed to perform automated isolation and purification of nucleic acids in molecular diagnostic and/or molecular biology applications. The system is intended for use by professional users, such as technicians and physicians trained in molecular biological techniques and the operation of the system.
Mas detalles

Nucleic Acid Purification Instrument
QIAsymphony AS

The QIAsymphony AS nucleic acid purification instrument is designed to perform automated assay setup in molecular diagnostic and/or molecular biology applications. It is intended for use by professional users, such as technicians and physicians trained in molecular biological techniques and the operation of the instrument.
Mas detalles

HPV Detection Test
Hybrid Capture 2

The Hybrid Capture 2 Modular System is for use with Hybrid Capture 2 (HC2) technology, such as the digene HC2 High-Risk HPV DNA Test, digene HC2 CT-ID DNA Test, and digene HC2 GC-ID DNA Test. The system processes specimens collected in Specimen Transport Medium (STM), which is part of the digene Cervical Sampler.
Mas detalles

Luminometer
DML 3000

The DML 3000 is a luminometer that automates amplified chemiluminescent signal detection and results reporting for HC2 assays, including the digene HC2 High-Risk HPV DNA Test. The benchtop, computer-controlled instrument measures light in the visible spectrum (300–650 nm) and measures chemiluninescence from opaque microplates.
Mas detalles

CT/GC Test
digene HC2 CT/GC DNA Test

The digene HC2CT/GC DNA Test is an in vitro nucleic microplate assay based on signal-amplified nucleic acid hybridization that uses chemiluminescence for the combined qualitative detection of DNA from Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) from cervical specimens. The kit is for labs that perform in vitro diagnostic tests and is meant to be used as an initial test to identify symptomatic or asymptomatic women with CT and/or GC infection.
Mas detalles

HPV Test
digene HC2 High-Risk HPV DNA Test

The digene HC2 High-Risk HPV DNA Test is an in vitro nucleic acid hybridization assay with signal amplification and chemiluminescence for the qualitative detection of 13 types of human papillomavirus (HPV) in cervical specimens. The test is suitable for high- or low-volume testing and is FDA-approved for in vitro diagnostic use.
Mas detalles

Rupture of Fetal Membranes Test
AmniSure ROM Test

The AmniSure ROM Test (Rupture of [fetal] Membranes test) is intended for the detection of PAMG-1 in amniotic fluid found in the vaginal discharge of pregnant women. It uses amniotic fluid test strips to detect the PAMG-1 protein marker of the amniotic fluid in vaginal discharge and is used by health care professionals to aid in the detection of ROM in pregnant women reporting signs, symptoms, or complaints suggestive of ROM.
Mas detalles

Human Cytomegalovirus (CMV) DNA Test
artus CMV QS-RGQ MDx Kit

The artus CMV QS-RGQ MDx Kit is intended for the detection and quantitation of human cytomegalovirus (CMV) DNA in human EDTA plasma. The test is intended for use as an aid in the management of solid organ transplant patients who are undergoing anti-CMV therapy and can be used to assess CMV viral load response to antiviral drug therapy.
Mas detalles

RT-PCR Enzymes and Kits
QuantiNova Pathogen +IC Kit

The QuantiNova Pathogen +IC Kit is designed for sensitive, rapid real-time (RT)-PCR detection of pathogen nucleic acids using sequence-specific probes. The kit contains reagents for 4-plex real-time detection of user-defined pathogen targets (e.g., virus, bacteria, fungi, etc.) plus the QuantiNova Internal Control (IC) RNA or DNA. Both ICs and assay are included for use as extraction or amplification controls, allowing correct interpretation of negative detection results.
Mas detalles

DNA and RNA Purification Kit
QIAampMinElute Virus Kits

QIAamp MinElute Virus Kits simplify viral DNA and RNA purification with fast spin-column and vacuum procedures. The kits use starting sample volumes of up to 0.2 ml and combine the selective binding properties of a silica-based membrane with flexible elution volumes of between 20 and 150 μl. The QIAamp MinElute Virus Spin process can be fully automated on the QIAcube Connect.
Mas detalles

High Capacity Syndromic Testing Platform
QIAstat-Dx Rise

The QIAstat-Dx Rise is a high-capacity version of the QIAstat-Dx automated syndromic system with enhancements to the menu of tests for a fully integrated one-step molecular testing solution that provides results in about one hour. With a random access capacity of up to 18 different tests, it can provide diagnostic results for up to 56 tests in an eight-hour shift and 160 tests per day by using eight analytical modules.
Mas detalles

Digital PCR System
QIAcuity

The QIAcuity Digital PCR System is designed to deliver precise and multiplexed quantification results for mutation detection, copy number variation (CNV), gene expression studies, gene-editing analysis, and many more. The nanoplate-based system seamlessly integrates a standard dPCR workflow of partitioning, thermocycling and imaging into a walk-away automated platform with minimal hands-on time.
Mas detalles

Tuberculosis (TB) Test
QIAreach QuantiFERON-TB

The QIAreach QuantiFERON-TB is a portable device that enables the ultrasensitive digital detection of TB infection with an end-to-end workflow that is simple and cost efficient, and increases access to reliable Interferon Gamma Release Assay (IGRA) testing. Built on the proven QuantiFERON-TB Gold Plus technology, it uses blood samples to test for interferon-gamma molecules released from T-cells that have come into contact with TB bacteria. QIAreach QuantiFERON-TB runs these tests on the digital eHub and eStick system, a true walkaway solution with random access and no calibration or maintenance. QIAreach QuantiFERON TB testing requires one patient visit and produces an easy-to-read result in 20 minutes after sample incubation, with the ability to record and send results for improved data management, making it ideal for TB screening programs.
Mas detalles

Modular Syndromic Testing System
QIAstat-Dx (DiagCORE) Analyzer

The QIAstat-Dx (DiagCORE) Analyzer is a modular and scalable system designed to work in any clinical setting. The system runs application cartridges on demand from predefined assay protocols, via displayed step-by-step instructions, offering an intuitive and safe user experience. The QIAstat-Dx Analyzer and cartridges are designed as a closed system that contains on board all necessary reagents, enabling hands-off sample preparation.
Mas detalles

Gastrointestinal Panel
QIAstat-Dx Gastrointestinal Panel

The QIAstat-Dx Gastrointestinal Panel utilizes proven QIAGEN sample and assay technologies to provide clinical insights for patients with suspected gastrointestinal infections. It can accept liquid transport medium (200 µl), and detect 24 viral and bacterial pathogens in about an hour with less than one minute hands-on time.
Mas detalles

Respiratory Panel
QIAstat-Dx (DiagCORE) Respiratory Panel V2

The QIAstat-Dx (DiagCORE) Respiratory Panel V2 utilizes proven QIAGEN sample and assay technologies to provide clinical insights for patients with suspected upper respiratory infections. It can accept both direct swabs and liquid transport medium (300 µl), and detect 21 viral and bacterial pathogens in about an hour with less than one minute hands-on time.
Mas detalles

SARS-CoV-2 RUO Solution
QuantiFERON SARS-CoV-2 RUO

The QuantiFERON SARS-CoV-2 RUO solution is an original combination of blood collection tubes containing innovative specific peptides formulated to stimulate lymphocytes in heparinized whole blood involved in cell-mediated immunity. Plasma from the stimulated samples can then be used for detection of IFN-γ using a simple ELISA. The QuantiFERON SARS-CoV-2 RUO solution is composed of several components that can be ordered separately or combined to provide better research insights on patients’ immune status.
Mas detalles

SARS-CoV-2 Antigen Testing Device
QIAreach eHub

The QIAreach eHub portable SARS-CoV-2 antigen testing device, in combination with QIAreach assay eSticks, provides a simplified workflow for multiple in vitro diagnostic tests, using state-of-the-art nanoparticle fluorescence detection technology. QIAreach assay eSticks are single-use tests that include a lateral flow strip and optoelectronics that perform test measurements and interpret results. The QIAreach eHub provides power to the QIAreach test eStick to run the test when the test eStick is connected to any one of the eHub eStick ports. The QIAreach eHub visually communicates test progress and results to the user via a display screen specific to each eHub port.
Mas detalles

SARS-CoV-2 Primer Panel
QIAseq SARS-CoV-2 Primer Panel

The QIAseq SARS-CoV-2 Primer Panel combines both reverse transcription and whole genome enrichment of the viral RNA for targeting SARS-CoV-2 to generate amplicons for downstream library creation. When paired with a QIAseq FX DNA Library UDI Kit, sequencing-ready libraries compatible with Illumina platforms can be constructed. QIAseq SARS-CoV-2 primer pools utilize designs from the ARTIC V3 primers which have also gone through an in silico check to reduce chances for dimerization during sample enrichment.
Mas detalles

Viral RNA UM Kit
QIAprep& Viral RNA UM Kit

The QIAprep& Viral RNA UM Kit combines a liquid-based sample preparation step completed in only two minutes with real-time RT-PCR detection in a streamlined workflow. Users can automate this method with standard lab equipment for any throughput, assay and reaction need from single to multiplex testing. The kit is compatible with dual-labeled probes, e.g., TaqMan probes in multiplex one-step RT-PCR detection of one or more targets (altogether, up to 4 assays including the internal controls).
Mas detalles

PANEL RESPIRATORIO SARS-COV-2
QIAstat-Dx Respiratory SARS-CoV-2 Panel

El panel QIAstat-Dx Respiratory SARS-CoV-2 es un cartucho sindrómico multiplex que detecta y diferencia 21 objetivos respiratorios, incluido el SARS-CoV-2 de hisopos nasofaríngeos (NPS) eluídos en medios de transporte universal (MTU).
Mas detalles

SARS-CoV-2 Antibody Test
QIAreach Anti-SARS-CoV-2 Total Test

The QIAreach Anti-SARS-CoV-2 Total Test is a rapid, digital lateral flow serological test, using nanoparticle fluorescence, intended for qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma (heparin, EDTA). It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Mas detalles

SARS-CoV-2 Antigen Test
QIAreach SARS-CoV-2 Antigen Test

The QIAreach SARS-CoV-2 Antigen Test is a scalable, digital assay for the in vitro detection of the SARS-CoV-2 nucleocapsid protein antigen that allows testing up to eight patients simultaneously for SARS-CoV-2 infection with the first positive results in just two minutes. As part of the complete QIAreach solution for SARS-CoV-2 testing, the test will run simultaneously with the QIAreach Anti-SARS-CoV-2 Total Test on a single QIAreach eHub.
Mas detalles

Molecular System
NeuMoDx 288

The NeuMoDx 288 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the instrument is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
Mas detalles

Molecular System
NeuMoDx 96

The NeuMoDx 96 Molecular System is designed for the automated extraction and isolation of nucleic acids, as well as the automated amplification and detection of target nucleic acid sequences by fluorescence-based PCR. Consisting of the instrument with touchscreen computer, accessories, and reagents and consumables, the system is intended for in vitro diagnostic (IVD) use in performing NeuMoDx-validated nucleic acid testing in clinical laboratories.
Mas detalles

SARS-CoV-2 Assay
NeuMoDx SARS-CoV-2 Assay

The NeuMoDx SARS-CoV-2 Assay is a real-time RT-PCR diagnostic test intended for the qualitative detection of SARS-CoV-2 coronavirus RNA in nasal, nasopharyngeal and oropharyngeal swabs in transport medium, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. This test is performed on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems and is also for use with saliva specimens that are collected within a healthcare setting by individuals using the NeuMoDx Saliva Collection Kit when determined to be appropriate by a healthcare provider.
Mas detalles

Flu A/SARS-CoV-2 Test
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test

The NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test is a multiplex polymerase chain reaction (PCR) test that detects and differentiates influenzas A and B, respiratory syncytial virus (RSV) and SARS-CoV-2 infections within 80 minutes. The respiratory test takes advantage of the NeuMoDx 96 and NeuMoDx 288 molecular systems’ automated three-step workflow and has obtained CE-IVD approval for the use of saliva samples collected with the NeuMoDx Saliva Collection Kit, which includes a collection vial, stabilization tube and pipette.
Mas detalles

KRAS PCR Assay
therascreen KRAS RGQ PCR Kit

The therascreen KRAS RGQ PCR Kit is an FDA-approved, qualitative real-time PCR assay for the detection of specific mutations in the KRAS oncogene. The kit provides reagents optimized for rapid and sensitive detection of seven somatic mutations using the Rotor-Gene Q MDx instrument.
Mas detalles

ENSAYO DE PCR
ipsogen JAK2 RGQ PCR Kit

El Kit ipsogen JAK2 RGQ PCR, es para la detección del alelo JAK2 V617F/G1849T en el ADN genómico extraído de sangre total con EDTA. El ensayo RT-PCR se realiza en el instrumento Rotor-Gene Q MDx.
Mas detalles

PRUEBA PIK3CA
PIK3CA RGQ PCR Kit

El kit PIK3CA RGQ PCR es la primera prueba diagnóstica complementaria aprobada por la FDA para identificar pacientes con cáncer de mama avanzado. La prueba se basa en la detección de mutaciones específicas de PIK3CA en el ADN tumoral.
Mas detalles

In Vitro Diagnostic Test
QuantiFERON-TB Gold (QFT) Kit

The QuantiFERON-TB Gold (QFT) Kit is an in vitro diagnostic test that aids in the detection of M. tuberculosis infection. QFT is an interferon γ (IFNγ) release assay (IGRA) which measures the cell-mediated response to specific TB antigens in whole blood.
Mas detalles

Nucleic Acid Amplification & Detection System
Rotor-Gene Q MDx

The Rotor-Gene Q MDx enables high-precision IVD-validated real-time PCR analysis and offers outstanding thermal and optical performance due to its rotary format. Used in combination with QIAGEN’s broad portfolio of CE-IVD-marked PCR kits, it is highly suited for in vitro diagnostic applications.
Mas detalles

DNA/RNA Analysis System
QIAxcel Advanced

The QIAxcel Advanced System fully automates sensitive, high-resolution capillary electrophoresis of up to 96 samples per run and allows DNA fragment analysis of 12 samples to be performed in three minutes. It utilizes ready-to-run gel cartridges, which allow 96 samples to be analyzed with a minimum of hands-on interaction, thus reducing manual handling errors and eliminating the need for tedious gel preparation.
Mas detalles
Derecho de autor © 2000-2024 TradeMed.com. Todos los derechos reservados. | Términos y condiciones